Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Claritev CorpCTEV · Entity 5238 | Director · Pres., CEO & Executive Chair | August 27, 2026 | August 31, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Claritev Corp
Report date August 27, 2026 · Filed August 31, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A common stockSEC Table I · non-derivative | IndirectSpouse's Individual Retirement Account | 50,372 |
Reported balance
After 2026-08-27 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2026-08-27 · Purchase · Acquired 4,500 · Balance 50,372 F1: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $38.29 to $39.00, inclusive. The reporting person undertakes to provide Claritev Corporation, any security holder of Claritev Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4. |
| Class A common stockSEC Table I · non-derivative | IndirectSpouse's Individual Retirement Account | 52,322 |
Reported balance
After 2026-08-28 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2026-08-28 · Purchase · Acquired 1,950 · Balance 52,322 F2: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $38.36 to $38.50, inclusive. The reporting person undertakes to provide Claritev Corporation, any security holder of Claritev Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4. |
| Class A common stockSEC Table I · non-derivative | Direct | 498,353 |
Reported balance
Holding disclosure · report date 2026-08-27 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 498,353 |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $38.29 to $39.00, inclusive. The reporting person undertakes to provide Claritev Corporation, any security holder of Claritev Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4.
F2: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $38.36 to $38.50, inclusive. The reporting person undertakes to provide Claritev Corporation, any security holder of Claritev Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
CERNER Corp
Report date June 07, 2022 · Filed June 09, 2022
Section 16 reporting ended · disclosed 2022-06-09. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Indirectby 401(k) Plan | 0 |
Reported balance
After 2022-06-07 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2022-06-07 · Other · Disposed 539 · Balance 0 F1: This Form 4 reports securities disposed of pursuant to the terms of the Tender Offer Statement on Schedule TO (together with any amendments and supplements hereto) filed by Cedar Acquisition Corporation ("Merger Subsidiary") in connection with the Agreement and Plan of Merger, dated December 20, 2021 (as it may be amended or supplemented from time to time, the "Merger Agreement"), between Cerner Corporation ("Cerner") and Merger Subsidiary, which is a wholly owned subsidiary of OC Acquisition LLC ("Parent"), Parent, which is a wholly owned subsidiary of Oracle Corporation ("Oracle"), and Oracle. Pursuant to the Merger Agreement, on January 19, 2022, Oracle commenced a cash tender offer (the "Offer") to acquire all of the issued and outstanding shares of Cerner common stock for a purchase price of $95.00 per share, net to the holders thereof in cash, without interest and subject to any required tax withholding. On June 7, 2022, Oracle accepted all shares tendered in the Offer. |
| Common StockSEC Table I · non-derivative | Indirectby ASPP account | 0 |
Reported balance
After 2022-06-07 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2022-06-07 · Other · Disposed 454 · Balance 0 F1: This Form 4 reports securities disposed of pursuant to the terms of the Tender Offer Statement on Schedule TO (together with any amendments and supplements hereto) filed by Cedar Acquisition Corporation ("Merger Subsidiary") in connection with the Agreement and Plan of Merger, dated December 20, 2021 (as it may be amended or supplemented from time to time, the "Merger Agreement"), between Cerner Corporation ("Cerner") and Merger Subsidiary, which is a wholly owned subsidiary of OC Acquisition LLC ("Parent"), Parent, which is a wholly owned subsidiary of Oracle Corporation ("Oracle"), and Oracle. Pursuant to the Merger Agreement, on January 19, 2022, Oracle commenced a cash tender offer (the "Offer") to acquire all of the issued and outstanding shares of Cerner common stock for a purchase price of $95.00 per share, net to the holders thereof in cash, without interest and subject to any required tax withholding. On June 7, 2022, Oracle accepted all shares tendered in the Offer. |
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2022-06-07 transaction · row 3
1 source rowRow 3 · 2022-06-07 · Other · Disposed 19,188 · Balance 0 F1: This Form 4 reports securities disposed of pursuant to the terms of the Tender Offer Statement on Schedule TO (together with any amendments and supplements hereto) filed by Cedar Acquisition Corporation ("Merger Subsidiary") in connection with the Agreement and Plan of Merger, dated December 20, 2021 (as it may be amended or supplemented from time to time, the "Merger Agreement"), between Cerner Corporation ("Cerner") and Merger Subsidiary, which is a wholly owned subsidiary of OC Acquisition LLC ("Parent"), Parent, which is a wholly owned subsidiary of Oracle Corporation ("Oracle"), and Oracle. Pursuant to the Merger Agreement, on January 19, 2022, Oracle commenced a cash tender offer (the "Offer") to acquire all of the issued and outstanding shares of Cerner common stock for a purchase price of $95.00 per share, net to the holders thereof in cash, without interest and subject to any required tax withholding. On June 7, 2022, Oracle accepted all shares tendered in the Offer. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $65.27 · Expires 2027-05-01 | Direct | 0 |
Reported balance
After 2022-06-08 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2022-06-08 · Disposition to issuer · Disposed 5,000 · Balance 0 F2: This Form 4 reports derivative securities disposed of pursuant to the Merger Agreement, pursuant to which Merger Subsidiary merged into Cerner, effective on June 8, 2022 (the "Effective Time"), with Cerner becoming a wholly owned indirect subsidiary of Oracle. At the Effective Time, each unvested restricted stock unit ("RSU") and unvested stock option was assumed by Oracle and converted into a number of Oracle RSUs and stock options, as applicable, based on the Award Exchange Ratio (as defined in the Merger Agreement), with the exercise price of the stock options accordingly adjusted, on the same vesting terms, all in accordance with the Merger Agreement. Each vested stock option and each RSU or stock option that vested on the Effective Time, was cancelled and converted into the right to receive the Compensatory Award Payment (as defined in the Merger Agreement). The Merger Agreement was filed by Cerner on December 20, 2021, as Exhibit 2.1 to Form 8-K. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $57.24 · Expires 2028-05-04 | Direct | 0 |
Reported balance
After 2022-06-08 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2022-06-08 · Disposition to issuer · Disposed 9,698 · Balance 0 F2: This Form 4 reports derivative securities disposed of pursuant to the Merger Agreement, pursuant to which Merger Subsidiary merged into Cerner, effective on June 8, 2022 (the "Effective Time"), with Cerner becoming a wholly owned indirect subsidiary of Oracle. At the Effective Time, each unvested restricted stock unit ("RSU") and unvested stock option was assumed by Oracle and converted into a number of Oracle RSUs and stock options, as applicable, based on the Award Exchange Ratio (as defined in the Merger Agreement), with the exercise price of the stock options accordingly adjusted, on the same vesting terms, all in accordance with the Merger Agreement. Each vested stock option and each RSU or stock option that vested on the Effective Time, was cancelled and converted into the right to receive the Compensatory Award Payment (as defined in the Merger Agreement). The Merger Agreement was filed by Cerner on December 20, 2021, as Exhibit 2.1 to Form 8-K. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $65.88 · Expires 2029-04-29 | Direct | 0 |
Reported balance
After 2022-06-08 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2022-06-08 · Disposition to issuer · Disposed 6,441 · Balance 0 F2: This Form 4 reports derivative securities disposed of pursuant to the Merger Agreement, pursuant to which Merger Subsidiary merged into Cerner, effective on June 8, 2022 (the "Effective Time"), with Cerner becoming a wholly owned indirect subsidiary of Oracle. At the Effective Time, each unvested restricted stock unit ("RSU") and unvested stock option was assumed by Oracle and converted into a number of Oracle RSUs and stock options, as applicable, based on the Award Exchange Ratio (as defined in the Merger Agreement), with the exercise price of the stock options accordingly adjusted, on the same vesting terms, all in accordance with the Merger Agreement. Each vested stock option and each RSU or stock option that vested on the Effective Time, was cancelled and converted into the right to receive the Compensatory Award Payment (as defined in the Merger Agreement). The Merger Agreement was filed by Cerner on December 20, 2021, as Exhibit 2.1 to Form 8-K. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Expires 2023-04-28 | Direct | 0 |
Reported balance
After 2022-06-08 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2022-06-08 · Disposition to issuer · Disposed 4,804 · Balance 0 F2: This Form 4 reports derivative securities disposed of pursuant to the Merger Agreement, pursuant to which Merger Subsidiary merged into Cerner, effective on June 8, 2022 (the "Effective Time"), with Cerner becoming a wholly owned indirect subsidiary of Oracle. At the Effective Time, each unvested restricted stock unit ("RSU") and unvested stock option was assumed by Oracle and converted into a number of Oracle RSUs and stock options, as applicable, based on the Award Exchange Ratio (as defined in the Merger Agreement), with the exercise price of the stock options accordingly adjusted, on the same vesting terms, all in accordance with the Merger Agreement. Each vested stock option and each RSU or stock option that vested on the Effective Time, was cancelled and converted into the right to receive the Compensatory Award Payment (as defined in the Merger Agreement). The Merger Agreement was filed by Cerner on December 20, 2021, as Exhibit 2.1 to Form 8-K. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Expires 2023-02-12 | Direct | 0 |
Reported balance
After 2022-06-08 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2022-06-08 · Disposition to issuer · Disposed 3,336 · Balance 0 F2: This Form 4 reports derivative securities disposed of pursuant to the Merger Agreement, pursuant to which Merger Subsidiary merged into Cerner, effective on June 8, 2022 (the "Effective Time"), with Cerner becoming a wholly owned indirect subsidiary of Oracle. At the Effective Time, each unvested restricted stock unit ("RSU") and unvested stock option was assumed by Oracle and converted into a number of Oracle RSUs and stock options, as applicable, based on the Award Exchange Ratio (as defined in the Merger Agreement), with the exercise price of the stock options accordingly adjusted, on the same vesting terms, all in accordance with the Merger Agreement. Each vested stock option and each RSU or stock option that vested on the Effective Time, was cancelled and converted into the right to receive the Compensatory Award Payment (as defined in the Merger Agreement). The Merger Agreement was filed by Cerner on December 20, 2021, as Exhibit 2.1 to Form 8-K. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Expires 2023-04-28 | Direct | 0 |
Reported balance
After 2022-06-08 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2022-06-08 · Disposition to issuer · Disposed 13,741 · Balance 0 F2: This Form 4 reports derivative securities disposed of pursuant to the Merger Agreement, pursuant to which Merger Subsidiary merged into Cerner, effective on June 8, 2022 (the "Effective Time"), with Cerner becoming a wholly owned indirect subsidiary of Oracle. At the Effective Time, each unvested restricted stock unit ("RSU") and unvested stock option was assumed by Oracle and converted into a number of Oracle RSUs and stock options, as applicable, based on the Award Exchange Ratio (as defined in the Merger Agreement), with the exercise price of the stock options accordingly adjusted, on the same vesting terms, all in accordance with the Merger Agreement. Each vested stock option and each RSU or stock option that vested on the Effective Time, was cancelled and converted into the right to receive the Compensatory Award Payment (as defined in the Merger Agreement). The Merger Agreement was filed by Cerner on December 20, 2021, as Exhibit 2.1 to Form 8-K. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Expires 2024-05-07 | Direct | 0 |
Reported balance
After 2022-06-08 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2022-06-08 · Disposition to issuer · Disposed 21,954 · Balance 0 F2: This Form 4 reports derivative securities disposed of pursuant to the Merger Agreement, pursuant to which Merger Subsidiary merged into Cerner, effective on June 8, 2022 (the "Effective Time"), with Cerner becoming a wholly owned indirect subsidiary of Oracle. At the Effective Time, each unvested restricted stock unit ("RSU") and unvested stock option was assumed by Oracle and converted into a number of Oracle RSUs and stock options, as applicable, based on the Award Exchange Ratio (as defined in the Merger Agreement), with the exercise price of the stock options accordingly adjusted, on the same vesting terms, all in accordance with the Merger Agreement. Each vested stock option and each RSU or stock option that vested on the Effective Time, was cancelled and converted into the right to receive the Compensatory Award Payment (as defined in the Merger Agreement). The Merger Agreement was filed by Cerner on December 20, 2021, as Exhibit 2.1 to Form 8-K. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Expires 2025-03-04 | Direct | 0 |
Reported balance
After 2022-06-08 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2022-06-08 · Disposition to issuer · Disposed 16,851 · Balance 0 F2: This Form 4 reports derivative securities disposed of pursuant to the Merger Agreement, pursuant to which Merger Subsidiary merged into Cerner, effective on June 8, 2022 (the "Effective Time"), with Cerner becoming a wholly owned indirect subsidiary of Oracle. At the Effective Time, each unvested restricted stock unit ("RSU") and unvested stock option was assumed by Oracle and converted into a number of Oracle RSUs and stock options, as applicable, based on the Award Exchange Ratio (as defined in the Merger Agreement), with the exercise price of the stock options accordingly adjusted, on the same vesting terms, all in accordance with the Merger Agreement. Each vested stock option and each RSU or stock option that vested on the Effective Time, was cancelled and converted into the right to receive the Compensatory Award Payment (as defined in the Merger Agreement). The Merger Agreement was filed by Cerner on December 20, 2021, as Exhibit 2.1 to Form 8-K. |
Filing footnotes · ownership attribution and instrument terms
F1: This Form 4 reports securities disposed of pursuant to the terms of the Tender Offer Statement on Schedule TO (together with any amendments and supplements hereto) filed by Cedar Acquisition Corporation ("Merger Subsidiary") in connection with the Agreement and Plan of Merger, dated December 20, 2021 (as it may be amended or supplemented from time to time, the "Merger Agreement"), between Cerner Corporation ("Cerner") and Merger Subsidiary, which is a wholly owned subsidiary of OC Acquisition LLC ("Parent"), Parent, which is a wholly owned subsidiary of Oracle Corporation ("Oracle"), and Oracle. Pursuant to the Merger Agreement, on January 19, 2022, Oracle commenced a cash tender offer (the "Offer") to acquire all of the issued and outstanding shares of Cerner common stock for a purchase price of $95.00 per share, net to the holders thereof in cash, without interest and subject to any required tax withholding. On June 7, 2022, Oracle accepted all shares tendered in the Offer.
F2: This Form 4 reports derivative securities disposed of pursuant to the Merger Agreement, pursuant to which Merger Subsidiary merged into Cerner, effective on June 8, 2022 (the "Effective Time"), with Cerner becoming a wholly owned indirect subsidiary of Oracle. At the Effective Time, each unvested restricted stock unit ("RSU") and unvested stock option was assumed by Oracle and converted into a number of Oracle RSUs and stock options, as applicable, based on the Award Exchange Ratio (as defined in the Merger Agreement), with the exercise price of the stock options accordingly adjusted, on the same vesting terms, all in accordance with the Merger Agreement. Each vested stock option and each RSU or stock option that vested on the Effective Time, was cancelled and converted into the right to receive the Compensatory Award Payment (as defined in the Merger Agreement). The Merger Agreement was filed by Cerner on December 20, 2021, as Exhibit 2.1 to Form 8-K.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 28, 2026 Filed Aug 31, 2026 12:50 UTC | Claritev Corp CTEV · Entity 5238 | PurchaseClass A common stock | 1,950 | $38.48 | $75,040.49 |
DisclosureSEC source: 0001628280-26-059472 · wk-form4_1788180614.xml · nonDerivative · entry 2 Dalton Travis · CIK 0001841409 · Director · Pres., CEO & Executive Chair 10b5-1 filing: No plan indicated Ownership: Indirect · Spouse's Individual Retirement Account Disclosed balance after: 52,322 F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $38.36 to $38.50, inclusive. The reporting person undertakes to provide Claritev Corporation, any security holder of Claritev Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| August 27, 2026 Filed Aug 31, 2026 12:50 UTC | Claritev Corp CTEV · Entity 5238 | PurchaseClass A common stock | 4,500 | $38.81 | $174,623.40 |
DisclosureSEC source: 0001628280-26-059472 · wk-form4_1788180614.xml · nonDerivative · entry 1 Dalton Travis · CIK 0001841409 · Director · Pres., CEO & Executive Chair 10b5-1 filing: No plan indicated Ownership: Indirect · Spouse's Individual Retirement Account Disclosed balance after: 50,372 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $38.29 to $39.00, inclusive. The reporting person undertakes to provide Claritev Corporation, any security holder of Claritev Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| May 18, 2026 Filed May 19, 2026 20:07 UTC | Claritev Corp CTEV · Entity 5238 | PurchaseClass A common stock | 11,200 | $11.88 | $133,056.00 |
DisclosureSEC source: 0001841409-26-000007 · wk-form4_1779221252.xml · nonDerivative · entry 2 Dalton Travis · CIK 0001841409 · Director · Pres., CEO & Executive Chair 10b5-1 filing: No plan indicated Ownership: Indirect · Spouse's Individual Retirement Account Disclosed balance after: 45,872 F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $11.58 to $12.00, inclusive. The reporting person undertakes to provide Claritev Corporation, any security holder of Claritev Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| May 18, 2026 Filed May 19, 2026 20:07 UTC | Claritev Corp CTEV · Entity 5238 | PurchaseClass A common stock | 9,720 | $12.92 | $125,582.40 |
DisclosureSEC source: 0001841409-26-000007 · wk-form4_1779221252.xml · nonDerivative · entry 1 Dalton Travis · CIK 0001841409 · Director · Pres., CEO & Executive Chair 10b5-1 filing: No plan indicated Ownership: Indirect · Spouse's Individual Retirement Account Disclosed balance after: 34,672 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.41 to $13.02, inclusive. The reporting person undertakes to provide Claritev Corporation, any security holder of Claritev Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 23:00 UTC | Claritev Corp CTEV · Entity 5238 | Disposition to issuerCash Settled Restricted Stock Units · Derivative | 190,566 | $0.00 | $0.00 |
DisclosureSEC source: 0001841409-26-000005 · wk-form4_1772578819.xml · derivative · entry 5 Dalton Travis · CIK 0001841409 · Director · Pres., CEO & Executive Chair 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 190,567 Underlying: Class A common stock · 190,566 shares Expires not disclosed F4 · derivative.exercise_price: Represents the cash settlement of cash settled restricted stock units ("cRSUs") granted on March 1, 2025 as a result of the vesting of 50% of such cRSUs on March 1, 2026. F4 · derivative.exercise_date: Represents the cash settlement of cash settled restricted stock units ("cRSUs") granted on March 1, 2025 as a result of the vesting of 50% of such cRSUs on March 1, 2026. F4 · derivative.expiration_date: Represents the cash settlement of cash settled restricted stock units ("cRSUs") granted on March 1, 2025 as a result of the vesting of 50% of such cRSUs on March 1, 2026. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 23:00 UTC | Claritev Corp CTEV · Entity 5238 | GrantClass A common stock | 278,925 | $0.00 | $0.00 |
DisclosureSEC source: 0001841409-26-000005 · wk-form4_1772578819.xml · nonDerivative · entry 3 Dalton Travis · CIK 0001841409 · Director · Pres., CEO & Executive Chair 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 498,353 F3 · kind: Represents a grant of restricted stock units which will vest at a rate of 25% per year on each of March 1, 2027, 2028, 2029, and 2030. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 23:00 UTC | Claritev Corp CTEV · Entity 5238 | Tax withholdingClass A common stock | 9,824 | $13.47 | $132,329.28 |
DisclosureSEC source: 0001841409-26-000005 · wk-form4_1772578819.xml · nonDerivative · entry 2 Dalton Travis · CIK 0001841409 · Director · Pres., CEO & Executive Chair 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 219,428 F2 · kind: Represents shares withheld to pay taxes applicable to vesting of restricted stock units granted on March 1, 2025. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 23:00 UTC | Claritev Corp CTEV · Entity 5238 | Tax withholdingClass A common stock | 13,806 | $13.47 | $185,966.82 |
DisclosureSEC source: 0001841409-26-000005 · wk-form4_1772578819.xml · nonDerivative · entry 1 Dalton Travis · CIK 0001841409 · Director · Pres., CEO & Executive Chair 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 229,252 F1 · kind: Represents shares withheld to pay taxes applicable to vesting of restricted stock units granted on March 1, 2024. Read SEC document |
| February 27, 2026 Filed Mar 2, 2026 21:38 UTC | Claritev Corp CTEV · Entity 5238 | PurchaseClass A common stock | 15,380 | $13.00 | $199,927.70 |
DisclosureSEC source: 0001841409-26-000003 · wk-form4_1772487511.xml · nonDerivative · entry 1 Dalton Travis · CIK 0001841409 · Director · Pres., CEO & Executive Chair 10b5-1 filing: No plan indicated Ownership: Indirect · Spouse's Individual Retirement Account Disclosed balance after: 24,952 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.940 to $13.000, inclusive. The reporting person undertakes to provide Claritev Corporation, any security holder of Claritev Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form-4. Read SEC document |
| November 20, 2025 Filed Nov 20, 2025 22:57 UTC | Claritev Corp CTEV · Entity 5238 | PurchaseClass A common stock | 5,290 | $47.23 | $249,841.94 |
DisclosureSEC source: 0001841409-25-000004 · wk-form4_1763679425.xml · nonDerivative · entry 1 Dalton Travis · CIK 0001841409 · Director · Pres., CEO & Executive Chair 10b5-1 filing: No plan indicated Ownership: Indirect · Spouse's Individual Retirement Account Disclosed balance after: 9,572 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $47.0000 to $47.2300, inclusive. The reporting person undertakes to provide Claritev Corporation, any security holder of Claritev Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form-4. Read SEC document |
| August 11, 2025 Filed Aug 12, 2025 20:19 UTC | Claritev Corp CTEV · Entity 5238 | PurchaseClass A common stock | 3,982 | $58.30 | $232,158.17 |
DisclosureSEC source: 0001793229-25-000142 · wk-form4_1755029947.xml · nonDerivative · entry 2 Dalton Travis · CIK 0001841409 · Director · Pres., CEO & Executive Chair 10b5-1 filing: No plan indicated Ownership: Indirect · Spouse's Individual Retirement Account Disclosed balance after: 4,282 F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $58.06 to $58.5, inclusive. The reporting person undertakes to provide Claritev Corporation, any security holder of Claritev Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| August 08, 2025 Filed Aug 12, 2025 20:19 UTC | Claritev Corp CTEV · Entity 5238 | PurchaseClass A common stock | 300 | $54.21 | $16,262.49 |
DisclosureSEC source: 0001793229-25-000142 · wk-form4_1755029947.xml · nonDerivative · entry 1 Dalton Travis · CIK 0001841409 · Director · Pres., CEO & Executive Chair 10b5-1 filing: No plan indicated Ownership: Indirect · Spouse's Individual Retirement Account Disclosed balance after: 300 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $54.18 to $54.25, inclusive. The reporting person undertakes to provide Claritev Corporation, any security holder of Claritev Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form-4. Read SEC document |
| May 15, 2025 Filed May 16, 2025 20:23 UTC | Claritev Corp CTEV · Entity 5238 | PurchaseClass A common stock | 3,773 | $26.50 | $99,984.50 |
DisclosureSEC source: 0001793229-25-000118 · wk-form4_1747427017.xml · nonDerivative · entry 1 Dalton Travis · CIK 0001841409 · Director · Pres., CEO & Executive Chair 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 243,058 Read SEC document |
| March 07, 2025 Filed Mar 10, 2025 20:43 UTC | Claritev Corp CTEV · Entity 5238 | PurchaseClass A common stock | 5,252 | $19.20 | $100,822.64 |
DisclosureSEC source: 0001793229-25-000065 · wk-form4_1741639405.xml · nonDerivative · entry 1 Dalton Travis · CIK 0001841409 · Director · Pres., CEO & Executive Chair 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 239,285 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $19.13 to $19.20, inclusive. The reporting person undertakes to provide Claritev Corporation, any security holder of Claritev Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form-4. Read SEC document |
| March 01, 2025 Filed Mar 5, 2025 02:38 UTC | Claritev Corp CTEV · Entity 5238 | GrantCash Settled Restricted Stock Units · Derivative | 381,133 | $0.00 | $0.00 |
DisclosureSEC source: 0001793229-25-000048 · wk-form4_1741142299.xml · derivative · entry 3 Dalton Travis · CIK 0001841409 · Director · Pres., CEO & Executive Chair 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 381,133 Underlying: Class A common stock · 381,133 shares Expires not disclosed F3 · derivative.exercise_price: Represents cash settled restricted stock units (cRSUs) vesting 50%/year on March 1, 2026 and 2027. Each cRSU is the economic equivalent of a share of Class A common stock (the Common Stock) of Claritev Corp. (the Company) and will be settled in cash based on the fair market value (FMV) per share of the Common Stock at settlement, subject to a cap of 4x the FMV of a share of Common Stock on the grant date (the cap) if settled prior to a change in control (CiC) of the Company (as defined in the award agreement). If settled at the cap, the Reporting Person will become entitled to receive a payment per cRSU equal to the lesser of, if positive, (i) the price per share received by the Company's stockholders in the CiC and (ii) the FMV of a share of Common Stock at the original settlement date, less the cap, if a CiC occurs on or prior to the 5th anniversary following the grant date. Any such excess will be paid on the earlier of the 5th anniversary of the grant date and certain CiCs. F3 · derivative.exercise_date: Represents cash settled restricted stock units (cRSUs) vesting 50%/year on March 1, 2026 and 2027. Each cRSU is the economic equivalent of a share of Class A common stock (the Common Stock) of Claritev Corp. (the Company) and will be settled in cash based on the fair market value (FMV) per share of the Common Stock at settlement, subject to a cap of 4x the FMV of a share of Common Stock on the grant date (the cap) if settled prior to a change in control (CiC) of the Company (as defined in the award agreement). If settled at the cap, the Reporting Person will become entitled to receive a payment per cRSU equal to the lesser of, if positive, (i) the price per share received by the Company's stockholders in the CiC and (ii) the FMV of a share of Common Stock at the original settlement date, less the cap, if a CiC occurs on or prior to the 5th anniversary following the grant date. Any such excess will be paid on the earlier of the 5th anniversary of the grant date and certain CiCs. F3 · derivative.expiration_date: Represents cash settled restricted stock units (cRSUs) vesting 50%/year on March 1, 2026 and 2027. Each cRSU is the economic equivalent of a share of Class A common stock (the Common Stock) of Claritev Corp. (the Company) and will be settled in cash based on the fair market value (FMV) per share of the Common Stock at settlement, subject to a cap of 4x the FMV of a share of Common Stock on the grant date (the cap) if settled prior to a change in control (CiC) of the Company (as defined in the award agreement). If settled at the cap, the Reporting Person will become entitled to receive a payment per cRSU equal to the lesser of, if positive, (i) the price per share received by the Company's stockholders in the CiC and (ii) the FMV of a share of Common Stock at the original settlement date, less the cap, if a CiC occurs on or prior to the 5th anniversary following the grant date. Any such excess will be paid on the earlier of the 5th anniversary of the grant date and certain CiCs. Read SEC document |
| March 01, 2025 Filed Mar 5, 2025 02:38 UTC | Claritev Corp CTEV · Entity 5238 | GrantClass A common stock | 127,203 | $0.00 | $0.00 |
DisclosureSEC source: 0001793229-25-000048 · wk-form4_1741142299.xml · nonDerivative · entry 2 Dalton Travis · CIK 0001841409 · Director · Pres., CEO & Executive Chair 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 234,033 F2 · kind: Represents a grant of restricted stock units which will vest at a rate of 25% per year on each of March 1, 2026, 2027, 2028, and 2029. Read SEC document |
| March 01, 2025 Filed Mar 5, 2025 02:38 UTC | Claritev Corp CTEV · Entity 5238 | Tax withholdingClass A common stock | 18,282 | $20.99 | $383,739.18 |
DisclosureSEC source: 0001793229-25-000048 · wk-form4_1741142299.xml · nonDerivative · entry 1 Dalton Travis · CIK 0001841409 · Director · Pres., CEO & Executive Chair 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 106,830 F1 · kind: Represents shares withheld to pay taxes applicable to vesting of restricted stock units granted on March 1, 2024. Read SEC document |
| August 07, 2024 Filed Aug 7, 2024 22:05 UTC | Claritev Corp MPLN · Entity 5238 | PurchaseClass A common stock | 500,000 | $0.37 | $185,000.00 |
DisclosureSEC source: 0001793229-24-000127 · wk-form4_1723068308.xml · nonDerivative · entry 1 Dalton Travis · CIK 0001841409 · Director · Pres., Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,004,504 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.31 to $0.43, inclusive. The reporting person undertakes to provide MultiPlan Corporation, any security holder of MultiPlan Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form-4. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:36 UTC | Claritev Corp MPLN · Entity 5238 | GrantStock Option · Derivative | 6,849,315 | $0.00 Strike: $1.11 | $0.00 |
DisclosureSEC source: 0001793229-24-000020 · wk-form4_1709674580.xml · derivative · entry 2 Dalton Travis · CIK 0001841409 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,849,315 Underlying: Class A common stock · 6,849,315 shares Expires 2034-03-01 F2 · derivative.exercise_date: The grant will vest, and become exercisable, at a rate of one-third per year on each of March 1, 2025, 2026, and 2027. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:36 UTC | Claritev Corp MPLN · Entity 5238 | GrantClass A common stock | 4,504,504 | $1.11 | $4,999,999.44 |
DisclosureSEC source: 0001793229-24-000020 · wk-form4_1709674580.xml · nonDerivative · entry 1 Dalton Travis · CIK 0001841409 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,504,504 F1 · kind: Represents a grant of restricted stock units which will vest at a rate of 50% per year on each of March 1, 2025 and 2026. Read SEC document |
| June 08, 2022 Filed Jun 9, 2022 17:22 UTC | CERNER Corp CERN · Entity 126375 | Disposition to issuerRestricted Stock Units · Derivative | 16,851 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-035488 · doc4.xml · derivative · entry 11 Dalton Travis · CIK 0001841409 · EVP & Chief Client & Serv. Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,851 shares Expires 2025-03-04 F2 · derivative.exercise_price: This Form 4 reports derivative securities disposed of pursuant to the Merger Agreement, pursuant to which Merger Subsidiary merged into Cerner, effective on June 8, 2022 (the "Effective Time"), with Cerner becoming a wholly owned indirect subsidiary of Oracle. At the Effective Time, each unvested restricted stock unit ("RSU") and unvested stock option was assumed by Oracle and converted into a number of Oracle RSUs and stock options, as applicable, based on the Award Exchange Ratio (as defined in the Merger Agreement), with the exercise price of the stock options accordingly adjusted, on the same vesting terms, all in accordance with the Merger Agreement. Each vested stock option and each RSU or stock option that vested on the Effective Time, was cancelled and converted into the right to receive the Compensatory Award Payment (as defined in the Merger Agreement). The Merger Agreement was filed by Cerner on December 20, 2021, as Exhibit 2.1 to Form 8-K. F2 · kind: This Form 4 reports derivative securities disposed of pursuant to the Merger Agreement, pursuant to which Merger Subsidiary merged into Cerner, effective on June 8, 2022 (the "Effective Time"), with Cerner becoming a wholly owned indirect subsidiary of Oracle. At the Effective Time, each unvested restricted stock unit ("RSU") and unvested stock option was assumed by Oracle and converted into a number of Oracle RSUs and stock options, as applicable, based on the Award Exchange Ratio (as defined in the Merger Agreement), with the exercise price of the stock options accordingly adjusted, on the same vesting terms, all in accordance with the Merger Agreement. Each vested stock option and each RSU or stock option that vested on the Effective Time, was cancelled and converted into the right to receive the Compensatory Award Payment (as defined in the Merger Agreement). The Merger Agreement was filed by Cerner on December 20, 2021, as Exhibit 2.1 to Form 8-K. F2 · price: This Form 4 reports derivative securities disposed of pursuant to the Merger Agreement, pursuant to which Merger Subsidiary merged into Cerner, effective on June 8, 2022 (the "Effective Time"), with Cerner becoming a wholly owned indirect subsidiary of Oracle. At the Effective Time, each unvested restricted stock unit ("RSU") and unvested stock option was assumed by Oracle and converted into a number of Oracle RSUs and stock options, as applicable, based on the Award Exchange Ratio (as defined in the Merger Agreement), with the exercise price of the stock options accordingly adjusted, on the same vesting terms, all in accordance with the Merger Agreement. Each vested stock option and each RSU or stock option that vested on the Effective Time, was cancelled and converted into the right to receive the Compensatory Award Payment (as defined in the Merger Agreement). The Merger Agreement was filed by Cerner on December 20, 2021, as Exhibit 2.1 to Form 8-K. Read SEC document |
| June 08, 2022 Filed Jun 9, 2022 17:22 UTC | CERNER Corp CERN · Entity 126375 | Disposition to issuerRestricted Stock Units · Derivative | 21,954 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-035488 · doc4.xml · derivative · entry 10 Dalton Travis · CIK 0001841409 · EVP & Chief Client & Serv. Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 21,954 shares Expires 2024-05-07 F2 · derivative.exercise_price: This Form 4 reports derivative securities disposed of pursuant to the Merger Agreement, pursuant to which Merger Subsidiary merged into Cerner, effective on June 8, 2022 (the "Effective Time"), with Cerner becoming a wholly owned indirect subsidiary of Oracle. At the Effective Time, each unvested restricted stock unit ("RSU") and unvested stock option was assumed by Oracle and converted into a number of Oracle RSUs and stock options, as applicable, based on the Award Exchange Ratio (as defined in the Merger Agreement), with the exercise price of the stock options accordingly adjusted, on the same vesting terms, all in accordance with the Merger Agreement. Each vested stock option and each RSU or stock option that vested on the Effective Time, was cancelled and converted into the right to receive the Compensatory Award Payment (as defined in the Merger Agreement). The Merger Agreement was filed by Cerner on December 20, 2021, as Exhibit 2.1 to Form 8-K. F2 · kind: This Form 4 reports derivative securities disposed of pursuant to the Merger Agreement, pursuant to which Merger Subsidiary merged into Cerner, effective on June 8, 2022 (the "Effective Time"), with Cerner becoming a wholly owned indirect subsidiary of Oracle. At the Effective Time, each unvested restricted stock unit ("RSU") and unvested stock option was assumed by Oracle and converted into a number of Oracle RSUs and stock options, as applicable, based on the Award Exchange Ratio (as defined in the Merger Agreement), with the exercise price of the stock options accordingly adjusted, on the same vesting terms, all in accordance with the Merger Agreement. Each vested stock option and each RSU or stock option that vested on the Effective Time, was cancelled and converted into the right to receive the Compensatory Award Payment (as defined in the Merger Agreement). The Merger Agreement was filed by Cerner on December 20, 2021, as Exhibit 2.1 to Form 8-K. F2 · price: This Form 4 reports derivative securities disposed of pursuant to the Merger Agreement, pursuant to which Merger Subsidiary merged into Cerner, effective on June 8, 2022 (the "Effective Time"), with Cerner becoming a wholly owned indirect subsidiary of Oracle. At the Effective Time, each unvested restricted stock unit ("RSU") and unvested stock option was assumed by Oracle and converted into a number of Oracle RSUs and stock options, as applicable, based on the Award Exchange Ratio (as defined in the Merger Agreement), with the exercise price of the stock options accordingly adjusted, on the same vesting terms, all in accordance with the Merger Agreement. Each vested stock option and each RSU or stock option that vested on the Effective Time, was cancelled and converted into the right to receive the Compensatory Award Payment (as defined in the Merger Agreement). The Merger Agreement was filed by Cerner on December 20, 2021, as Exhibit 2.1 to Form 8-K. Read SEC document |
| June 08, 2022 Filed Jun 9, 2022 17:22 UTC | CERNER Corp CERN · Entity 126375 | Disposition to issuerRestricted Stock Units · Derivative | 13,741 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-035488 · doc4.xml · derivative · entry 9 Dalton Travis · CIK 0001841409 · EVP & Chief Client & Serv. Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,741 shares Expires 2023-04-28 F2 · derivative.exercise_price: This Form 4 reports derivative securities disposed of pursuant to the Merger Agreement, pursuant to which Merger Subsidiary merged into Cerner, effective on June 8, 2022 (the "Effective Time"), with Cerner becoming a wholly owned indirect subsidiary of Oracle. At the Effective Time, each unvested restricted stock unit ("RSU") and unvested stock option was assumed by Oracle and converted into a number of Oracle RSUs and stock options, as applicable, based on the Award Exchange Ratio (as defined in the Merger Agreement), with the exercise price of the stock options accordingly adjusted, on the same vesting terms, all in accordance with the Merger Agreement. Each vested stock option and each RSU or stock option that vested on the Effective Time, was cancelled and converted into the right to receive the Compensatory Award Payment (as defined in the Merger Agreement). The Merger Agreement was filed by Cerner on December 20, 2021, as Exhibit 2.1 to Form 8-K. F2 · kind: This Form 4 reports derivative securities disposed of pursuant to the Merger Agreement, pursuant to which Merger Subsidiary merged into Cerner, effective on June 8, 2022 (the "Effective Time"), with Cerner becoming a wholly owned indirect subsidiary of Oracle. At the Effective Time, each unvested restricted stock unit ("RSU") and unvested stock option was assumed by Oracle and converted into a number of Oracle RSUs and stock options, as applicable, based on the Award Exchange Ratio (as defined in the Merger Agreement), with the exercise price of the stock options accordingly adjusted, on the same vesting terms, all in accordance with the Merger Agreement. Each vested stock option and each RSU or stock option that vested on the Effective Time, was cancelled and converted into the right to receive the Compensatory Award Payment (as defined in the Merger Agreement). The Merger Agreement was filed by Cerner on December 20, 2021, as Exhibit 2.1 to Form 8-K. F2 · price: This Form 4 reports derivative securities disposed of pursuant to the Merger Agreement, pursuant to which Merger Subsidiary merged into Cerner, effective on June 8, 2022 (the "Effective Time"), with Cerner becoming a wholly owned indirect subsidiary of Oracle. At the Effective Time, each unvested restricted stock unit ("RSU") and unvested stock option was assumed by Oracle and converted into a number of Oracle RSUs and stock options, as applicable, based on the Award Exchange Ratio (as defined in the Merger Agreement), with the exercise price of the stock options accordingly adjusted, on the same vesting terms, all in accordance with the Merger Agreement. Each vested stock option and each RSU or stock option that vested on the Effective Time, was cancelled and converted into the right to receive the Compensatory Award Payment (as defined in the Merger Agreement). The Merger Agreement was filed by Cerner on December 20, 2021, as Exhibit 2.1 to Form 8-K. Read SEC document |
| June 08, 2022 Filed Jun 9, 2022 17:22 UTC | CERNER Corp CERN · Entity 126375 | Disposition to issuerRestricted Stock Units · Derivative | 3,336 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-035488 · doc4.xml · derivative · entry 8 Dalton Travis · CIK 0001841409 · EVP & Chief Client & Serv. Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,336 shares Expires 2023-02-12 F2 · derivative.exercise_price: This Form 4 reports derivative securities disposed of pursuant to the Merger Agreement, pursuant to which Merger Subsidiary merged into Cerner, effective on June 8, 2022 (the "Effective Time"), with Cerner becoming a wholly owned indirect subsidiary of Oracle. At the Effective Time, each unvested restricted stock unit ("RSU") and unvested stock option was assumed by Oracle and converted into a number of Oracle RSUs and stock options, as applicable, based on the Award Exchange Ratio (as defined in the Merger Agreement), with the exercise price of the stock options accordingly adjusted, on the same vesting terms, all in accordance with the Merger Agreement. Each vested stock option and each RSU or stock option that vested on the Effective Time, was cancelled and converted into the right to receive the Compensatory Award Payment (as defined in the Merger Agreement). The Merger Agreement was filed by Cerner on December 20, 2021, as Exhibit 2.1 to Form 8-K. F2 · kind: This Form 4 reports derivative securities disposed of pursuant to the Merger Agreement, pursuant to which Merger Subsidiary merged into Cerner, effective on June 8, 2022 (the "Effective Time"), with Cerner becoming a wholly owned indirect subsidiary of Oracle. At the Effective Time, each unvested restricted stock unit ("RSU") and unvested stock option was assumed by Oracle and converted into a number of Oracle RSUs and stock options, as applicable, based on the Award Exchange Ratio (as defined in the Merger Agreement), with the exercise price of the stock options accordingly adjusted, on the same vesting terms, all in accordance with the Merger Agreement. Each vested stock option and each RSU or stock option that vested on the Effective Time, was cancelled and converted into the right to receive the Compensatory Award Payment (as defined in the Merger Agreement). The Merger Agreement was filed by Cerner on December 20, 2021, as Exhibit 2.1 to Form 8-K. F2 · price: This Form 4 reports derivative securities disposed of pursuant to the Merger Agreement, pursuant to which Merger Subsidiary merged into Cerner, effective on June 8, 2022 (the "Effective Time"), with Cerner becoming a wholly owned indirect subsidiary of Oracle. At the Effective Time, each unvested restricted stock unit ("RSU") and unvested stock option was assumed by Oracle and converted into a number of Oracle RSUs and stock options, as applicable, based on the Award Exchange Ratio (as defined in the Merger Agreement), with the exercise price of the stock options accordingly adjusted, on the same vesting terms, all in accordance with the Merger Agreement. Each vested stock option and each RSU or stock option that vested on the Effective Time, was cancelled and converted into the right to receive the Compensatory Award Payment (as defined in the Merger Agreement). The Merger Agreement was filed by Cerner on December 20, 2021, as Exhibit 2.1 to Form 8-K. Read SEC document |
| June 08, 2022 Filed Jun 9, 2022 17:22 UTC | CERNER Corp CERN · Entity 126375 | Disposition to issuerRestricted Stock Units · Derivative | 4,804 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-035488 · doc4.xml · derivative · entry 7 Dalton Travis · CIK 0001841409 · EVP & Chief Client & Serv. Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,804 shares Expires 2023-04-28 F2 · derivative.exercise_price: This Form 4 reports derivative securities disposed of pursuant to the Merger Agreement, pursuant to which Merger Subsidiary merged into Cerner, effective on June 8, 2022 (the "Effective Time"), with Cerner becoming a wholly owned indirect subsidiary of Oracle. At the Effective Time, each unvested restricted stock unit ("RSU") and unvested stock option was assumed by Oracle and converted into a number of Oracle RSUs and stock options, as applicable, based on the Award Exchange Ratio (as defined in the Merger Agreement), with the exercise price of the stock options accordingly adjusted, on the same vesting terms, all in accordance with the Merger Agreement. Each vested stock option and each RSU or stock option that vested on the Effective Time, was cancelled and converted into the right to receive the Compensatory Award Payment (as defined in the Merger Agreement). The Merger Agreement was filed by Cerner on December 20, 2021, as Exhibit 2.1 to Form 8-K. F2 · kind: This Form 4 reports derivative securities disposed of pursuant to the Merger Agreement, pursuant to which Merger Subsidiary merged into Cerner, effective on June 8, 2022 (the "Effective Time"), with Cerner becoming a wholly owned indirect subsidiary of Oracle. At the Effective Time, each unvested restricted stock unit ("RSU") and unvested stock option was assumed by Oracle and converted into a number of Oracle RSUs and stock options, as applicable, based on the Award Exchange Ratio (as defined in the Merger Agreement), with the exercise price of the stock options accordingly adjusted, on the same vesting terms, all in accordance with the Merger Agreement. Each vested stock option and each RSU or stock option that vested on the Effective Time, was cancelled and converted into the right to receive the Compensatory Award Payment (as defined in the Merger Agreement). The Merger Agreement was filed by Cerner on December 20, 2021, as Exhibit 2.1 to Form 8-K. F2 · price: This Form 4 reports derivative securities disposed of pursuant to the Merger Agreement, pursuant to which Merger Subsidiary merged into Cerner, effective on June 8, 2022 (the "Effective Time"), with Cerner becoming a wholly owned indirect subsidiary of Oracle. At the Effective Time, each unvested restricted stock unit ("RSU") and unvested stock option was assumed by Oracle and converted into a number of Oracle RSUs and stock options, as applicable, based on the Award Exchange Ratio (as defined in the Merger Agreement), with the exercise price of the stock options accordingly adjusted, on the same vesting terms, all in accordance with the Merger Agreement. Each vested stock option and each RSU or stock option that vested on the Effective Time, was cancelled and converted into the right to receive the Compensatory Award Payment (as defined in the Merger Agreement). The Merger Agreement was filed by Cerner on December 20, 2021, as Exhibit 2.1 to Form 8-K. Read SEC document |
| June 08, 2022 Filed Jun 9, 2022 17:22 UTC | CERNER Corp CERN · Entity 126375 | Disposition to issuerNon-Qualified Stock Option (right to buy) · Derivative | 6,441 | Not disclosed Strike: $65.88 | Not disclosed |
DisclosureSEC source: 0001209191-22-035488 · doc4.xml · derivative · entry 6 Dalton Travis · CIK 0001841409 · EVP & Chief Client & Serv. Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,441 shares Expires 2029-04-29 F2 · derivative.exercise_price: This Form 4 reports derivative securities disposed of pursuant to the Merger Agreement, pursuant to which Merger Subsidiary merged into Cerner, effective on June 8, 2022 (the "Effective Time"), with Cerner becoming a wholly owned indirect subsidiary of Oracle. At the Effective Time, each unvested restricted stock unit ("RSU") and unvested stock option was assumed by Oracle and converted into a number of Oracle RSUs and stock options, as applicable, based on the Award Exchange Ratio (as defined in the Merger Agreement), with the exercise price of the stock options accordingly adjusted, on the same vesting terms, all in accordance with the Merger Agreement. Each vested stock option and each RSU or stock option that vested on the Effective Time, was cancelled and converted into the right to receive the Compensatory Award Payment (as defined in the Merger Agreement). The Merger Agreement was filed by Cerner on December 20, 2021, as Exhibit 2.1 to Form 8-K. F2 · kind: This Form 4 reports derivative securities disposed of pursuant to the Merger Agreement, pursuant to which Merger Subsidiary merged into Cerner, effective on June 8, 2022 (the "Effective Time"), with Cerner becoming a wholly owned indirect subsidiary of Oracle. At the Effective Time, each unvested restricted stock unit ("RSU") and unvested stock option was assumed by Oracle and converted into a number of Oracle RSUs and stock options, as applicable, based on the Award Exchange Ratio (as defined in the Merger Agreement), with the exercise price of the stock options accordingly adjusted, on the same vesting terms, all in accordance with the Merger Agreement. Each vested stock option and each RSU or stock option that vested on the Effective Time, was cancelled and converted into the right to receive the Compensatory Award Payment (as defined in the Merger Agreement). The Merger Agreement was filed by Cerner on December 20, 2021, as Exhibit 2.1 to Form 8-K. F2 · price: This Form 4 reports derivative securities disposed of pursuant to the Merger Agreement, pursuant to which Merger Subsidiary merged into Cerner, effective on June 8, 2022 (the "Effective Time"), with Cerner becoming a wholly owned indirect subsidiary of Oracle. At the Effective Time, each unvested restricted stock unit ("RSU") and unvested stock option was assumed by Oracle and converted into a number of Oracle RSUs and stock options, as applicable, based on the Award Exchange Ratio (as defined in the Merger Agreement), with the exercise price of the stock options accordingly adjusted, on the same vesting terms, all in accordance with the Merger Agreement. Each vested stock option and each RSU or stock option that vested on the Effective Time, was cancelled and converted into the right to receive the Compensatory Award Payment (as defined in the Merger Agreement). The Merger Agreement was filed by Cerner on December 20, 2021, as Exhibit 2.1 to Form 8-K. Read SEC document |
| June 08, 2022 Filed Jun 9, 2022 17:22 UTC | CERNER Corp CERN · Entity 126375 | Disposition to issuerNon-Qualified Stock Option (right to buy) · Derivative | 9,698 | Not disclosed Strike: $57.24 | Not disclosed |
DisclosureSEC source: 0001209191-22-035488 · doc4.xml · derivative · entry 5 Dalton Travis · CIK 0001841409 · EVP & Chief Client & Serv. Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,698 shares Expires 2028-05-04 F2 · derivative.exercise_price: This Form 4 reports derivative securities disposed of pursuant to the Merger Agreement, pursuant to which Merger Subsidiary merged into Cerner, effective on June 8, 2022 (the "Effective Time"), with Cerner becoming a wholly owned indirect subsidiary of Oracle. At the Effective Time, each unvested restricted stock unit ("RSU") and unvested stock option was assumed by Oracle and converted into a number of Oracle RSUs and stock options, as applicable, based on the Award Exchange Ratio (as defined in the Merger Agreement), with the exercise price of the stock options accordingly adjusted, on the same vesting terms, all in accordance with the Merger Agreement. Each vested stock option and each RSU or stock option that vested on the Effective Time, was cancelled and converted into the right to receive the Compensatory Award Payment (as defined in the Merger Agreement). The Merger Agreement was filed by Cerner on December 20, 2021, as Exhibit 2.1 to Form 8-K. F2 · kind: This Form 4 reports derivative securities disposed of pursuant to the Merger Agreement, pursuant to which Merger Subsidiary merged into Cerner, effective on June 8, 2022 (the "Effective Time"), with Cerner becoming a wholly owned indirect subsidiary of Oracle. At the Effective Time, each unvested restricted stock unit ("RSU") and unvested stock option was assumed by Oracle and converted into a number of Oracle RSUs and stock options, as applicable, based on the Award Exchange Ratio (as defined in the Merger Agreement), with the exercise price of the stock options accordingly adjusted, on the same vesting terms, all in accordance with the Merger Agreement. Each vested stock option and each RSU or stock option that vested on the Effective Time, was cancelled and converted into the right to receive the Compensatory Award Payment (as defined in the Merger Agreement). The Merger Agreement was filed by Cerner on December 20, 2021, as Exhibit 2.1 to Form 8-K. F2 · price: This Form 4 reports derivative securities disposed of pursuant to the Merger Agreement, pursuant to which Merger Subsidiary merged into Cerner, effective on June 8, 2022 (the "Effective Time"), with Cerner becoming a wholly owned indirect subsidiary of Oracle. At the Effective Time, each unvested restricted stock unit ("RSU") and unvested stock option was assumed by Oracle and converted into a number of Oracle RSUs and stock options, as applicable, based on the Award Exchange Ratio (as defined in the Merger Agreement), with the exercise price of the stock options accordingly adjusted, on the same vesting terms, all in accordance with the Merger Agreement. Each vested stock option and each RSU or stock option that vested on the Effective Time, was cancelled and converted into the right to receive the Compensatory Award Payment (as defined in the Merger Agreement). The Merger Agreement was filed by Cerner on December 20, 2021, as Exhibit 2.1 to Form 8-K. Read SEC document |
| June 08, 2022 Filed Jun 9, 2022 17:22 UTC | CERNER Corp CERN · Entity 126375 | Disposition to issuerNon-Qualified Stock Option (right to buy) · Derivative | 5,000 | Not disclosed Strike: $65.27 | Not disclosed |
DisclosureSEC source: 0001209191-22-035488 · doc4.xml · derivative · entry 4 Dalton Travis · CIK 0001841409 · EVP & Chief Client & Serv. Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2027-05-01 F2 · derivative.exercise_price: This Form 4 reports derivative securities disposed of pursuant to the Merger Agreement, pursuant to which Merger Subsidiary merged into Cerner, effective on June 8, 2022 (the "Effective Time"), with Cerner becoming a wholly owned indirect subsidiary of Oracle. At the Effective Time, each unvested restricted stock unit ("RSU") and unvested stock option was assumed by Oracle and converted into a number of Oracle RSUs and stock options, as applicable, based on the Award Exchange Ratio (as defined in the Merger Agreement), with the exercise price of the stock options accordingly adjusted, on the same vesting terms, all in accordance with the Merger Agreement. Each vested stock option and each RSU or stock option that vested on the Effective Time, was cancelled and converted into the right to receive the Compensatory Award Payment (as defined in the Merger Agreement). The Merger Agreement was filed by Cerner on December 20, 2021, as Exhibit 2.1 to Form 8-K. F2 · kind: This Form 4 reports derivative securities disposed of pursuant to the Merger Agreement, pursuant to which Merger Subsidiary merged into Cerner, effective on June 8, 2022 (the "Effective Time"), with Cerner becoming a wholly owned indirect subsidiary of Oracle. At the Effective Time, each unvested restricted stock unit ("RSU") and unvested stock option was assumed by Oracle and converted into a number of Oracle RSUs and stock options, as applicable, based on the Award Exchange Ratio (as defined in the Merger Agreement), with the exercise price of the stock options accordingly adjusted, on the same vesting terms, all in accordance with the Merger Agreement. Each vested stock option and each RSU or stock option that vested on the Effective Time, was cancelled and converted into the right to receive the Compensatory Award Payment (as defined in the Merger Agreement). The Merger Agreement was filed by Cerner on December 20, 2021, as Exhibit 2.1 to Form 8-K. F2 · price: This Form 4 reports derivative securities disposed of pursuant to the Merger Agreement, pursuant to which Merger Subsidiary merged into Cerner, effective on June 8, 2022 (the "Effective Time"), with Cerner becoming a wholly owned indirect subsidiary of Oracle. At the Effective Time, each unvested restricted stock unit ("RSU") and unvested stock option was assumed by Oracle and converted into a number of Oracle RSUs and stock options, as applicable, based on the Award Exchange Ratio (as defined in the Merger Agreement), with the exercise price of the stock options accordingly adjusted, on the same vesting terms, all in accordance with the Merger Agreement. Each vested stock option and each RSU or stock option that vested on the Effective Time, was cancelled and converted into the right to receive the Compensatory Award Payment (as defined in the Merger Agreement). The Merger Agreement was filed by Cerner on December 20, 2021, as Exhibit 2.1 to Form 8-K. Read SEC document |
| June 07, 2022 Filed Jun 9, 2022 17:22 UTC | CERNER Corp CERN · Entity 126375 | OtherCommon Stock | 19,188 | $95.00 | $1,822,860.00 |
DisclosureSEC source: 0001209191-22-035488 · doc4.xml · nonDerivative · entry 3 Dalton Travis · CIK 0001841409 · EVP & Chief Client & Serv. Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: This Form 4 reports securities disposed of pursuant to the terms of the Tender Offer Statement on Schedule TO (together with any amendments and supplements hereto) filed by Cedar Acquisition Corporation ("Merger Subsidiary") in connection with the Agreement and Plan of Merger, dated December 20, 2021 (as it may be amended or supplemented from time to time, the "Merger Agreement"), between Cerner Corporation ("Cerner") and Merger Subsidiary, which is a wholly owned subsidiary of OC Acquisition LLC ("Parent"), Parent, which is a wholly owned subsidiary of Oracle Corporation ("Oracle"), and Oracle. Pursuant to the Merger Agreement, on January 19, 2022, Oracle commenced a cash tender offer (the "Offer") to acquire all of the issued and outstanding shares of Cerner common stock for a purchase price of $95.00 per share, net to the holders thereof in cash, without interest and subject to any required tax withholding. On June 7, 2022, Oracle accepted all shares tendered in the Offer. F1 · price: This Form 4 reports securities disposed of pursuant to the terms of the Tender Offer Statement on Schedule TO (together with any amendments and supplements hereto) filed by Cedar Acquisition Corporation ("Merger Subsidiary") in connection with the Agreement and Plan of Merger, dated December 20, 2021 (as it may be amended or supplemented from time to time, the "Merger Agreement"), between Cerner Corporation ("Cerner") and Merger Subsidiary, which is a wholly owned subsidiary of OC Acquisition LLC ("Parent"), Parent, which is a wholly owned subsidiary of Oracle Corporation ("Oracle"), and Oracle. Pursuant to the Merger Agreement, on January 19, 2022, Oracle commenced a cash tender offer (the "Offer") to acquire all of the issued and outstanding shares of Cerner common stock for a purchase price of $95.00 per share, net to the holders thereof in cash, without interest and subject to any required tax withholding. On June 7, 2022, Oracle accepted all shares tendered in the Offer. Read SEC document |
| June 07, 2022 Filed Jun 9, 2022 17:22 UTC | CERNER Corp CERN · Entity 126375 | OtherCommon Stock | 454 | $95.00 | $43,130.00 |
DisclosureSEC source: 0001209191-22-035488 · doc4.xml · nonDerivative · entry 2 Dalton Travis · CIK 0001841409 · EVP & Chief Client & Serv. Off 10b5-1 filing: Not disclosed Ownership: Indirect · by ASPP account Disclosed balance after: 0 F1 · kind: This Form 4 reports securities disposed of pursuant to the terms of the Tender Offer Statement on Schedule TO (together with any amendments and supplements hereto) filed by Cedar Acquisition Corporation ("Merger Subsidiary") in connection with the Agreement and Plan of Merger, dated December 20, 2021 (as it may be amended or supplemented from time to time, the "Merger Agreement"), between Cerner Corporation ("Cerner") and Merger Subsidiary, which is a wholly owned subsidiary of OC Acquisition LLC ("Parent"), Parent, which is a wholly owned subsidiary of Oracle Corporation ("Oracle"), and Oracle. Pursuant to the Merger Agreement, on January 19, 2022, Oracle commenced a cash tender offer (the "Offer") to acquire all of the issued and outstanding shares of Cerner common stock for a purchase price of $95.00 per share, net to the holders thereof in cash, without interest and subject to any required tax withholding. On June 7, 2022, Oracle accepted all shares tendered in the Offer. F1 · price: This Form 4 reports securities disposed of pursuant to the terms of the Tender Offer Statement on Schedule TO (together with any amendments and supplements hereto) filed by Cedar Acquisition Corporation ("Merger Subsidiary") in connection with the Agreement and Plan of Merger, dated December 20, 2021 (as it may be amended or supplemented from time to time, the "Merger Agreement"), between Cerner Corporation ("Cerner") and Merger Subsidiary, which is a wholly owned subsidiary of OC Acquisition LLC ("Parent"), Parent, which is a wholly owned subsidiary of Oracle Corporation ("Oracle"), and Oracle. Pursuant to the Merger Agreement, on January 19, 2022, Oracle commenced a cash tender offer (the "Offer") to acquire all of the issued and outstanding shares of Cerner common stock for a purchase price of $95.00 per share, net to the holders thereof in cash, without interest and subject to any required tax withholding. On June 7, 2022, Oracle accepted all shares tendered in the Offer. Read SEC document |
| June 07, 2022 Filed Jun 9, 2022 17:22 UTC | CERNER Corp CERN · Entity 126375 | OtherCommon Stock | 539 | $95.00 | $51,205.00 |
DisclosureSEC source: 0001209191-22-035488 · doc4.xml · nonDerivative · entry 1 Dalton Travis · CIK 0001841409 · EVP & Chief Client & Serv. Off 10b5-1 filing: Not disclosed Ownership: Indirect · by 401(k) Plan Disclosed balance after: 0 F1 · kind: This Form 4 reports securities disposed of pursuant to the terms of the Tender Offer Statement on Schedule TO (together with any amendments and supplements hereto) filed by Cedar Acquisition Corporation ("Merger Subsidiary") in connection with the Agreement and Plan of Merger, dated December 20, 2021 (as it may be amended or supplemented from time to time, the "Merger Agreement"), between Cerner Corporation ("Cerner") and Merger Subsidiary, which is a wholly owned subsidiary of OC Acquisition LLC ("Parent"), Parent, which is a wholly owned subsidiary of Oracle Corporation ("Oracle"), and Oracle. Pursuant to the Merger Agreement, on January 19, 2022, Oracle commenced a cash tender offer (the "Offer") to acquire all of the issued and outstanding shares of Cerner common stock for a purchase price of $95.00 per share, net to the holders thereof in cash, without interest and subject to any required tax withholding. On June 7, 2022, Oracle accepted all shares tendered in the Offer. F1 · price: This Form 4 reports securities disposed of pursuant to the terms of the Tender Offer Statement on Schedule TO (together with any amendments and supplements hereto) filed by Cedar Acquisition Corporation ("Merger Subsidiary") in connection with the Agreement and Plan of Merger, dated December 20, 2021 (as it may be amended or supplemented from time to time, the "Merger Agreement"), between Cerner Corporation ("Cerner") and Merger Subsidiary, which is a wholly owned subsidiary of OC Acquisition LLC ("Parent"), Parent, which is a wholly owned subsidiary of Oracle Corporation ("Oracle"), and Oracle. Pursuant to the Merger Agreement, on January 19, 2022, Oracle commenced a cash tender offer (the "Offer") to acquire all of the issued and outstanding shares of Cerner common stock for a purchase price of $95.00 per share, net to the holders thereof in cash, without interest and subject to any required tax withholding. On June 7, 2022, Oracle accepted all shares tendered in the Offer. Read SEC document |
| March 04, 2022 Filed Mar 8, 2022 16:06 UTC | CERNER Corp CERN · Entity 126375 | GrantRestricted Stock Units · Derivative | 16,851 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-017041 · doc4.xml · derivative · entry 4 Dalton Travis · CIK 0001841409 · EVP & Chief Client & Serv. Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,851 Underlying: Common Stock · 16,851 shares Expires 2025-03-04 F1 · derivative.exercise_price: The restricted stock units convert on a one for one basis for shares of common stock, without any consideration. F2 · shares: Each restricted stock unit represents a contingent right to receive one share of Cerner Corporation common stock. The restricted stock units are eligible for vesting, per the following schedule: 5,617 on 3/4/2023, 5,617 on 3/4/2024 and 5,617 on 3/4/2025, subject to continued employment through the respective vesting dates. F3 · price: This transaction represents a grant of restricted stock units to the reporting person by the issuer. Therefore, no consideration other than the value of services rendered was paid for the security. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 16:03 UTC | CERNER Corp CERN · Entity 126375 | GrantRestricted Stock Units · Derivative | 6,486 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-010695 · doc4.xml · derivative · entry 4 Dalton Travis · CIK 0001841409 · EVP & Chief Client & Serv. Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,741 Underlying: Common Stock · 6,486 shares Expires 2023-04-28 F1 · derivative.exercise_price: The RSUs convert on a one for basis for shares of common stock, without any consideration. F2 · shares: Reporting person was granted performance-based restricted stock units on April 30, 2020, which are earned based on the attainment of established performance criteria unrelated to the Company's stock price. As a result of our full year 2021 performance relative to the attainment of the established Adjusted Operating Margin performance targets, the number of shares listed in this Table II were banked upon Compensation Committee approval, and will be banked until April 28, 2023, the vest date, subject to continued employment through such date. Each restricted stock unit represents a contingent right to receive one share of Cerner Corporation common stock. F3 · price: This transaction represents a grant of restricted stock units to the reporting person by the issuer. Therefore, no consideration other than the value of services rendered was paid for the security. Read SEC document |
| December 31, 2021 Filed Jan 21, 2022 16:03 UTC | CERNER Corp CERN · Entity 126375 | OtherCommon Stock | 327 | $62.13 | $20,316.51 |
DisclosureSEC source: 0001209191-22-004383 · doc5.xml · nonDerivative · entry 2 Dalton Travis · CIK 0001841409 · EVP & Chief Client & Serv. Off 10b5-1 filing: Not disclosed Ownership: Indirect · by ASPP account Disclosed balance after: 759 F3 · kind: Represents shares purchased through the associate stock purchase plan (ASPP), an Internal Revenue Code Section 423 stock purchase plan, in transactions exempt under Rule 16b-3(c), at prices ranging from $59.92 to $79.62. F2 · price: Full information regarding the number of shares acquired at each separate price will be provided upon request by the Commission staff, Cerner Corporation, or a Cerner shareholder. F3 · price: Represents shares purchased through the associate stock purchase plan (ASPP), an Internal Revenue Code Section 423 stock purchase plan, in transactions exempt under Rule 16b-3(c), at prices ranging from $59.92 to $79.62. Read SEC document |
| December 31, 2021 Filed Jan 21, 2022 16:03 UTC | CERNER Corp CERN · Entity 126375 | OtherCommon Stock | 136 | $72.09 | $9,804.24 |
DisclosureSEC source: 0001209191-22-004383 · doc5.xml · nonDerivative · entry 1 Dalton Travis · CIK 0001841409 · EVP & Chief Client & Serv. Off 10b5-1 filing: Not disclosed Ownership: Indirect · by 401(k) Plan Disclosed balance after: 539 F1 · kind: Represents shares acquired through routine payroll deduction and participation in the issuer's 401(k) plan between 1/16/2021 and 12/31/2021, at prices ranging from $69.58 to $80.12 per share. Balance is based on plan statement as of 12/31/2021. This transaction qualifies as a non-discretionary transaction from a tax-qualified plan. F1 · price: Represents shares acquired through routine payroll deduction and participation in the issuer's 401(k) plan between 1/16/2021 and 12/31/2021, at prices ranging from $69.58 to $80.12 per share. Balance is based on plan statement as of 12/31/2021. This transaction qualifies as a non-discretionary transaction from a tax-qualified plan. F2 · price: Full information regarding the number of shares acquired at each separate price will be provided upon request by the Commission staff, Cerner Corporation, or a Cerner shareholder. Read SEC document |
| December 20, 2021 Filed Dec 22, 2021 16:59 UTC | CERNER Corp CERN · Entity 126375 | Exercise / conversionRestricted Stock Units · Derivative | 10,976 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-070941 · doc4.xml · derivative · entry 11 Dalton Travis · CIK 0001841409 · EVP & Chief Client & Serv. Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,954 Underlying: Common Stock · 10,976 shares Expires 2024-05-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: Reflects the accelerated vesting of restricted stock units for tax planning purposes in connection with the transactions contemplated by that certain merger agreement dated December 20, 2021. Read SEC document |
| December 20, 2021 Filed Dec 22, 2021 16:59 UTC | CERNER Corp CERN · Entity 126375 | Exercise / conversionRestricted Stock Units · Derivative | 3,336 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-070941 · doc4.xml · derivative · entry 10 Dalton Travis · CIK 0001841409 · EVP & Chief Client & Serv. Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,336 Underlying: Common Stock · 3,336 shares Expires 2023-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The restricted stock units convert on a one for one basis for shares of common stock, without any consideration. F3 · shares: Reflects the accelerated vesting of restricted stock units for tax planning purposes in connection with the transactions contemplated by that certain merger agreement dated December 20, 2021. Read SEC document |
| December 20, 2021 Filed Dec 22, 2021 16:59 UTC | CERNER Corp CERN · Entity 126375 | Exercise / conversionRestricted Stock Units · Derivative | 4,509 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-070941 · doc4.xml · derivative · entry 9 Dalton Travis · CIK 0001841409 · EVP & Chief Client & Serv. Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,509 shares Expires 2022-04-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The restricted stock units convert on a one for one basis for shares of common stock, without any consideration. F3 · shares: Reflects the accelerated vesting of restricted stock units for tax planning purposes in connection with the transactions contemplated by that certain merger agreement dated December 20, 2021. Read SEC document |
| December 20, 2021 Filed Dec 22, 2021 16:59 UTC | CERNER Corp CERN · Entity 126375 | Exercise / conversionRestricted Stock Units · Derivative | 4,804 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-070941 · doc4.xml · derivative · entry 8 Dalton Travis · CIK 0001841409 · EVP & Chief Client & Serv. Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,804 Underlying: Common Stock · 4,804 shares Expires 2023-04-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The restricted stock units convert on a one for one basis for shares of common stock, without any consideration. F3 · shares: Reflects the accelerated vesting of restricted stock units for tax planning purposes in connection with the transactions contemplated by that certain merger agreement dated December 20, 2021. Read SEC document |
| December 20, 2021 Filed Dec 22, 2021 16:59 UTC | CERNER Corp CERN · Entity 126375 | Tax withholdingCommon Stock | 9,074 | $90.49 | $821,106.26 |
DisclosureSEC source: 0001209191-21-070941 · doc4.xml · nonDerivative · entry 5 Dalton Travis · CIK 0001841409 · EVP & Chief Client & Serv. Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,883 F1 · shares: Shares withheld to satisfy the tax withholdings for the vesting of restricted stock units. Read SEC document |
| December 20, 2021 Filed Dec 22, 2021 16:59 UTC | CERNER Corp CERN · Entity 126375 | Exercise / conversionCommon Stock | 10,976 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-070941 · doc4.xml · nonDerivative · entry 4 Dalton Travis · CIK 0001841409 · EVP & Chief Client & Serv. Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,957 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 20, 2021 Filed Dec 22, 2021 16:59 UTC | CERNER Corp CERN · Entity 126375 | Exercise / conversionCommon Stock | 3,336 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-070941 · doc4.xml · nonDerivative · entry 3 Dalton Travis · CIK 0001841409 · EVP & Chief Client & Serv. Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,981 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 20, 2021 Filed Dec 22, 2021 16:59 UTC | CERNER Corp CERN · Entity 126375 | Exercise / conversionCommon Stock | 4,804 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-070941 · doc4.xml · nonDerivative · entry 2 Dalton Travis · CIK 0001841409 · EVP & Chief Client & Serv. Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,645 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 20, 2021 Filed Dec 22, 2021 16:59 UTC | CERNER Corp CERN · Entity 126375 | Exercise / conversionCommon Stock | 4,509 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-070941 · doc4.xml · nonDerivative · entry 1 Dalton Travis · CIK 0001841409 · EVP & Chief Client & Serv. Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,841 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 06, 2021 Filed Aug 10, 2021 09:06 UTC | CERNER Corp CERN · Entity 126375 | Tax withholdingCommon Stock | 1,344 | $80.00 | $107,520.00 |
DisclosureSEC source: 0001209191-21-050519 · doc4.xml · nonDerivative · entry 2 Dalton Travis · CIK 0001841409 · EVP & Chief Client & Serv. Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,332 F3 · shares: Shares withheld to satisfy the tax withholdings for the vesting of restricted stock units. Read SEC document |
| August 06, 2021 Filed Aug 10, 2021 09:06 UTC | CERNER Corp CERN · Entity 126375 | GrantCommon Stock | 2,981 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-050519 · doc4.xml · nonDerivative · entry 1 Dalton Travis · CIK 0001841409 · EVP & Chief Client & Serv. Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,676 F1 · shares: Reporting person was granted performance-based restricted stock units ("PSUs") on August 6, 2018, which are earned based on the attainment of certain criteria unrelated to the Company's stock price. Upon satisfaction of the performance criteria, on August 6, 2021, 2,981 PSUs vested. Each PSU represents a contingent right to receive one share of Cerner Corporation common stock. F2 · price: This transaction represents a grant of restricted stock units to the reporting person by the issuer. Therefore, no consideration other than the value of services rendered was paid for the security. Read SEC document |
| June 08, 2021 Filed Jan 21, 2022 16:03 UTC | CERNER Corp CERN · Entity 126375 | OtherCommon Stock | 305 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-004383 · doc5.xml · nonDerivative · entry 4 Dalton Travis · CIK 0001841409 · EVP & Chief Client & Serv. Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,188 F4 · kind: Represents a transfer of shares between ASPP account and direct account. Read SEC document |
| June 08, 2021 Filed Jan 21, 2022 16:03 UTC | CERNER Corp CERN · Entity 126375 | OtherCommon Stock | 305 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-004383 · doc5.xml · nonDerivative · entry 3 Dalton Travis · CIK 0001841409 · EVP & Chief Client & Serv. Off 10b5-1 filing: Not disclosed Ownership: Indirect · by ASPP account Disclosed balance after: 454 F4 · kind: Represents a transfer of shares between ASPP account and direct account. Read SEC document |
| June 04, 2021 Filed Jun 4, 2021 16:01 UTC | CERNER Corp CERN · Entity 126375 | OtherNon-Qualified Stock Option (right to buy) · Derivative | 3,221 | $0.00 Strike: $65.88 | $0.00 |
DisclosureSEC source: 0001209191-21-038180 · doc4.xml · derivative · entry 11 Dalton Travis · CIK 0001841409 · EVP & Chief Client & Serv. Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,441 Underlying: Common Stock · 3,221 shares Expires 2029-04-29 Read SEC document |
| June 04, 2021 Filed Jun 4, 2021 16:01 UTC | CERNER Corp CERN · Entity 126375 | OtherNon-Qualified Stock Option (right to buy) · Derivative | 4,849 | $0.00 Strike: $57.24 | $0.00 |
DisclosureSEC source: 0001209191-21-038180 · doc4.xml · derivative · entry 10 Dalton Travis · CIK 0001841409 · EVP & Chief Client & Serv. Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,698 Underlying: Common Stock · 4,849 shares Expires 2028-05-04 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.